A Study to Evaluate the Safety, Tolerability and Drug Levels of BMS-986447 in Healthy Participants - IM054-003
Updated: 5 September, 2023 | ClinicalTrials.gov
Inclusion Criteria: - Body mass index between 18 and 30 kilograms per metered square (kg/m^2), inclusive. - Healthy male and female participants without clinically significant deviation from normal in medical history, physical examination, ECG, and clinical laboratory determinations. - A negative COVID-19 test, which will be performed in the manner mandated by the clinical side where the study is being conducted, at screening and check-in Day -2. Exclusion Criteria: - Participant has any condition that confounds the ability to interpret data from the study. - Participant has any condition including the presence of laboratory abnormalities, which places the participant at unacceptable risk if the participant was to participate in the study. - Any major surgery or planned surgery (except gastrointestinal [GI] surgery, as described below) within 12 weeks of study intervention administration. Note: Other protocol-defined inclusion/exclusion criteria apply.